Abstract
AbstractSmall extracellular vesicles derived from human pluripotent stem cells (hPSCâsEVs) have shown great application potential in regenerative medicine. To standardise its research and clinical application, the first set of guidelines on hPSCâsEVs in China âRequirements for human pluripotent stem cell derived small extracellular vesiclesâ was released by the Chinese Research Hospital Association on 28 December 2021 and came into effect on 1 January 2022. It was jointly drafted and agreed upon by the experts from the Chinese Society of Extracellular Vesicles. This standard specifies the technical requirements, test methods and regulations, packaging, instructions for use, labelling, storage, transportation, and waste handling for hPSCâsEVs, which apply to the production and quality control of hPSCâsEVs. We hope that the publication of these guidelines will make it one step closer to international standardisation of hPSCâsEVs for research and application.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
